ResearcherHokkaido UniversityActive in the last 2 years
Osamu Sato
Matched on ORCID iD 0000-0002-0903-1650; OpenAlex author ID A5054945728. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers
Papers 5
- Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model. Co-author DOI 10.1016/j.biopha.2023.116052↗
- Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort stu… Co-author DOI 10.1186/s12893-024-02395-2↗
- Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. Co-author DOI 10.3390/cancers15030601↗
- Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.14023↗
- Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. Co-author DOI 10.18632/oncotarget.21939↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Satoshi Hirano · 5 shared papers, 2017–2024 · strength 0.66
- Paper Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal ad… DOI 10.1186/s12893-024-02395-2↗
- Paper Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in a… DOI 10.1016/j.biopha.2023.116052↗
- Paper Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. DOI 10.3390/cancers15030601↗
- Yuta Takeuchi · 3 shared papers, 2023–2024 · strength 0.53
- Paper Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal ad… DOI 10.1186/s12893-024-02395-2↗
- Paper Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in a… DOI 10.1016/j.biopha.2023.116052↗
- Paper Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. DOI 10.3390/cancers15030601↗
- Takahiro Tsuchikawa · 4 shared papers, 2017–2024 · strength 0.45
- Paper Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in a… DOI 10.1016/j.biopha.2023.116052↗
- Paper Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. DOI 10.3390/cancers15030601↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Shota Kuwabara · 3 shared papers, 2017–2024 · strength 0.34
- Paper Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal ad… DOI 10.1186/s12893-024-02395-2↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Toru Nakamura · 3 shared papers, 2017–2023 · strength 0.27
- Paper Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells. DOI 10.3390/cancers15030601↗
- Paper Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarc… DOI 10.1111/cas.14023↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Yuma Aoki · 1 shared paper, 2024 · strength 0.21
- Masato Ono · 2 shared papers, 2017–2019 · strength 0.13
- Toshiaki Shichinohe · 1 shared paper, 2019 · strength 0.07
- Yoshitsugu Nakanishi · 1 shared paper, 2019 · strength 0.07
- Toshimichi Asano · 1 shared paper, 2019 · strength 0.07
- Yuma Hane · 1 shared paper, 2019 · strength 0.07
- Hironobu Takano · 1 shared paper, 2017 · strength 0.05
- Shoki Sato · 1 shared paper, 2017 · strength 0.05
- Kazuho Inoko · 1 shared paper, 2017 · strength 0.05
- Shintaro Takeuchi · 1 shared paper, 2017 · strength 0.05
- Toshihiro Kushibiki · 1 shared paper, 2017 · strength 0.05
- Yusuke Nakamura · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.